Search clinical trials for: receptor occupancy
Total 17960 results
-
AbbVieNot yet recruiting
-
Intra-Cellular Therapies, Inc.RecruitingHealthy VolunteersUnited States
-
Yale UniversityJanssen Scientific Affairs, LLCNot yet recruitingMuscarinic Receptor OccupancyUnited States
-
Rigshospitalet, DenmarkRecruiting
-
Cerevel Therapeutics, LLCRecruiting
-
New York State Psychiatric InstituteNot yet recruiting
-
Charite University, Berlin, GermanyStiftung Institut fuer Herzinfarktforschung; Deutsches Zentrum für Herz-Kreislauf-Forschung... and other collaboratorsRecruitingAtrial FibrillationGermany
-
Novartis PharmaceuticalsCompletedMajor Depressive DisorderUnited Kingdom
-
Pliant Therapeutics, Inc.Stanford UniversityCompletedIdiopathic Pulmonary FibrosisUnited States
-
Cerevel Therapeutics, LLCCompletedSchizophreniaBelgium, United States
-
University of PennsylvaniaActive, not recruitingHealthy Volunteer | D3 Dopamine Receptor | Cocaine-dependentUnited States
-
Yale UniversityNational Institute on Aging (NIA)CompletedAlzheimer DiseaseUnited States
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Pipeline Therapeutics, Inc.Completed
-
AbbVieKU Leuven; Syndesi TherapeuticsCompleted
-
InvicroCompletedHealthy VolunteerUnited States
-
LB Pharmaceuticals Inc.Washington University School of MedicineCompletedSchizophreniaUnited States
-
PrileniaCompletedHealth Volunteers, Huntington DiseaseGermany
-
AstraZenecaCompletedHealthy VolunteersSweden
-
Heptares Therapeutics LimitedCompleted
-
National Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
H. Lundbeck A/SCompleted
-
PfizerTerminatedHodgkins LymphomaUnited Kingdom, United States, Italy
-
Centre for Addiction and Mental HealthUnknownSchizophrenia | Schizoaffective Disorder | Schizophreniform DisorderCanada
-
Janssen Research & Development, LLCTerminated
-
Seoul National University HospitalUnknownSchizophreniaKorea, Republic of
-
Seoul National University HospitalUnknown
-
InvicroCompletedHealthy Male VolunteersUnited States
-
Seoul National University HospitalCompletedSchizophrenia | Dopamine Receptor Occupancy | Medication Satisfaction | Prolactin LevelKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
PfizerYale UniversityCompleted
-
GlaxoSmithKlineCompleted
-
Janssen-Cilag International NVCompleted
-
Janssen-Cilag International NVCompleted
-
National Institute of Mental Health (NIMH)CompletedBaseline | Blocking Receptor BindingUnited States
-
Braeburn PharmaceuticalsCompletedSchizophreniaUnited States
-
GlaxoSmithKlineCompleted
-
Institute of Psychiatry, LondonTerminatedSchizophrenia | Alzheimer's DiseaseUnited Kingdom
-
Baylor College of MedicineNational Institute of Mental Health (NIMH)CompletedSmoking Cessation | SchizophreniaUnited States, China
-
Intra-Cellular Therapies, Inc.CompletedSchizophreniaUnited States
-
Taisho Pharmaceutical R&D Inc.Yale UniversityCompleted
-
BlackThorn Therapeutics, Inc.Completed
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedPruritusUnited Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Nabi BiopharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedChemotherapy-Induced Nausea and Vomiting (CINV)
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
PfizerCompleted